Ryan Chapman has joined Stifel’s Coeur d’Alene office as a financial adviser. Born and raised in Coeur d’Alene, Chapman is a ...

We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

A. O. Smith (NYSE:AOS – Free Report) had its price objective reduced by Stifel Nicolaus from $90.00 to $84.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating ...

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

A significant number of General Services Administration leases are set to expire during President Trump's second term in the White House. Here's St. Louis' exposure to potential cost-cutting efforts.

Ron Kruszewski, Stifel's chairman and CEO, told financial analysts that its investment banking franchise is well-positioned ...

John Cahill, an analyst from Stifel Nicolaus, maintained the Buy rating on Picton Property Income (PCTNF – Research Report). The associated ...

Stifel analysts, led by Brad Reback, have maintained their Buy rating on Microsoft Corporation (NASDAQ:MSFT), with a steady ...

Caesars Entertainment (NASDAQ:CZR – Free Report) had its price objective reduced by Stifel Nicolaus from $54.00 to $51.00 in ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...